SCHEMBL24316101

SCHEMBL24316101

CC(C)C(NCOCc1ccc2c3c(cccc13)N(C1CCC(=O)NC1=O)C2=O)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 18/20 0.41
DDB1 Q16531 17/20 0.41
BCL2L11 O43521 1/20 0.41
BCL2 P10415 1/20 0.41
MCL1 Q07820 1/20 0.41
IKZF3 Q9UKT9 2/20 0.40
ALDH1A1 P00352 1/20 0.40
CHRM2 P08172 1/20 0.40
OPRM1 P35372 1/20 0.40
CYP1A2 P05177 1/20 0.40
TSHR P16473 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
TNF P01375 1/20 0.38
IL1B P01584 1/20 0.38
TBXA2R P21731 1/20 0.38
IKZF1 Q13422 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24316100 0.84 CRBN (0.44) CRBNDDB1BCL2L11BCL2MCL1
SCHEMBL24317584 0.80 DDB1 (0.43) CRBNDDB1BCL2L11BCL2MCL1
SCHEMBL26620942 0.80 CRBN (0.54) CRBNDDB1BCL2L11BCL2MCL1
SCHEMBL24315758 0.79 CRBN (0.45) CRBNDDB1BCL2L11BCL2MCL1
SCHEMBL24316324 0.78 CRBN (0.54) CRBNDDB1BCL2L11BCL2MCL1
SCHEMBL29533020 0.77 CRBN (0.53) CRBNDDB1BCL2L11BCL2MCL1
SCHEMBL24317632 0.77 CRBN (0.53) CRBNDDB1BCL2L11BCL2MCL1
Hydrochloric Acid SCHEMBL26691522 0.76 CRBN (0.52) CRBNDDB1BCL2L11BCL2MCL1
SCHEMBL29583157 0.76 CRBN (0.54) CRBNDDB1BCL2L11BCL2MCL1
SCHEMBL27274481 0.75 CRBN (0.53) CRBNDDB1BCL2L11BCL2MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081925-A1 TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4 C4 THERAPEUTICS, INC. (US) 2022-04-21 WO disclosed
US-9585884-B2 Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2 AUSPEX PHARMACEUTICALS, INC. (US) 2017-03-07 US disclosed